Chr. Hansen Holding Past Earnings Performance

Past criteria checks 3/6

Chr. Hansen Holding's earnings have been declining at an average annual rate of -0.8%, while the Chemicals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 5.6% per year. Chr. Hansen Holding's return on equity is 11.9%, and it has net margins of 17%.

Key information

-0.8%

Earnings growth rate

-0.9%

EPS growth rate

Chemicals Industry Growth	12.9%
Revenue growth rate	5.6%
Return on equity	11.9%
Net Margin	17.0%
Next Earnings Update	04 Apr 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Chr. Hansen Holding makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:CRTS.F Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Aug 23	1,334	227	269	99
31 May 23	1,310	229	269	99
28 Feb 23	1,294	229	268	98
30 Nov 22	1,259	228	263	98
31 Aug 22	1,218	225	256	97
31 May 22	1,183	230	248	96
28 Feb 22	1,146	221	238	96
30 Nov 21	1,102	209	232	93
31 Aug 21	1,077	199	228	90
31 May 21	1,038	199	213	80
28 Feb 21	1,014	213	202	77
30 Nov 20	994	222	193	74
31 Aug 20	970	232	188	73
31 May 20	798	218	160	69
29 Feb 20	844	221	174	70
30 Nov 19	888	224	184	71
31 Aug 19	937	229	193	70
31 May 19	1,152	246	228	76
28 Feb 19	1,132	240	223	75
30 Nov 18	1,112	233	218	74
31 Aug 18	1,097	228	210	73
31 May 18	1,084	226	208	74
28 Feb 18	1,080	224	206	73
30 Nov 17	1,075	224	206	72
31 Aug 17	1,063	224	205	70
31 May 17	1,035	212	199	67
28 Feb 17	1,007	205	193	65
30 Nov 16	976	192	183	63
31 Aug 16	949	184	179	60
31 May 16	927	179	175	57
29 Feb 16	905	174	170	54
30 Nov 15	885	172	168	53
31 Aug 15	859	163	163	51
31 May 15	830	150	158	49
28 Feb 15	800	141	152	46
30 Nov 14	773	133	150	45
31 Aug 14	756	132	147	43
31 May 14	745	145	148	42
28 Feb 14	738	142	150	40
30 Nov 13	731	135	151	37
31 Aug 13	738	138	152	35
31 May 13	730	126	166	20
28 Feb 13	719	125	158	24

Quality Earnings: CRTS.F has high quality earnings.

Growing Profit Margin: CRTS.F's current net profit margins (17%) are lower than last year (18.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CRTS.F's earnings have declined by 0.8% per year over the past 5 years.

Accelerating Growth: CRTS.F's earnings growth over the past year (0.8%) exceeds its 5-year average (-0.8% per year).

Earnings vs Industry: CRTS.F earnings growth over the past year (0.8%) exceeded the Chemicals industry -6%.

Return on Equity

High ROE: CRTS.F's Return on Equity (11.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Chr. Hansen Holding Past Earnings Performance

Past criteria checks 3/6

Key information

Recent past performance updates

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Recent updates

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Chr. Hansen Holding A/S Declares Interim Dividend for the Period September 1, 2022 to August 31, 2023, Payable on October 17, 2023

Chr. Hansen Holding A/S Revises Revenue Guidance for January 1, 2023 – December 31, 2023

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S Approves Ordinary Dividend

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Chr. Hansen Holding A/S Proposes Ordinary Dividend for 2021/22

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

Chr. Hansen Announces Lillie Li Valeur Steps Down from the Board of Directors

Chr. Hansen Holding A/S Declares Extraordinary Dividend, Payable on May 20, 2021

Chr. Hansen Holding A/S Provides Revenue Guidance for the Year 2021

Chr. Hansen Holding A/S Approves Directorate Appointment

Chr. Hansen Holding A/S Announces Management Changes

Chr. Hansen Holding A/S (CPSE:CHR) completed the acquisition of Jennewein Biotechnologie GmbH.

EQT IX managed by EQT Partners AB entered into a definitive agreement to acquire Natural Colors business from Chr. Hansen Holding A/S (CPSE:CHR) for €800 million on cash and debt free basis.

Chr. Hansen Holding A/S (CPSE:CHR) entered into an agreement to acquire Jennewein Biotechnologie GmbH for €310 million.

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Revenue & Expenses Breakdown
Beta